» Articles » PMID: 39295440

Self-poisoning with Paracetamol in England: Short Report of Characteristics of Individuals and Their Overdoses According to Source of Tablets

Overview
Journal BJPsych Open
Specialty Psychiatry
Date 2024 Sep 19
PMID 39295440
Authors
Affiliations
Soon will be listed here.
Abstract

Self-poisoning with paracetamol is the most frequently used overdose method in the UK. Psychosocial assessments were conducted by mental health clinicians with 127 consecutive individuals who presented with pure paracetamol overdoses to a large general hospital over 8 months, including asking about the source of the tablets and scoring the patients' acts on the Beck Suicide Intent scale (BSI). Patients were predominantly female (86%) and young (79% aged 12-24 years). Most had used paracetamol which was available in the home (77%). Those who purchased paracetamol for the act took double the number of tablets compared with those who used paracetamol available in the home (37 18), had higher suicidal intent (mean BSI: 11 7) and more often required treatment with -acetyl cysteine (71% 43%). These results highlight the need for safer home storage of paracetamol and consideration of reducing pack size limits on paracetamol that can be purchased.

References
1.
Casey D, Geulayov G, Bale E, Brand F, Clements C, Kapur N . Paracetamol self-poisoning: Epidemiological study of trends and patient characteristics from the multicentre study of self-harm in England. J Affect Disord. 2020; 276:699-706. DOI: 10.1016/j.jad.2020.07.091. View

2.
Tsiachristas A, Geulayov G, Casey D, Ness J, Waters K, Clements C . Incidence and general hospital costs of self-harm across England: estimates based on the multicentre study of self-harm. Epidemiol Psychiatr Sci. 2020; 29:e108. PMC: 7214546. DOI: 10.1017/S2045796020000189. View

3.
Harriss L, Hawton K . Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the Suicide Intent Scale. J Affect Disord. 2005; 86(2-3):225-33. DOI: 10.1016/j.jad.2005.02.009. View

4.
Suda K, Callaway Kim K, Hernandez I, Gellad W, Rothenberger S, Campbell A . The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis. J Am Pharm Assoc (2003). 2022; 62(3):766-774.e6. PMC: 8704785. DOI: 10.1016/j.japh.2021.12.014. View

5.
Tsiachristas A, McDaid D, Casey D, Brand F, Leal J, Park A . General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis. Lancet Psychiatry. 2017; 4(10):759-767. PMC: 5614771. DOI: 10.1016/S2215-0366(17)30367-X. View